NLRP3 and metabolic dysfunction-associated steatohepatitis: The deregulated NLRP3 inflammasome is known to drive the progression of many inflammatory, metabolic, degenerative, and age-related diseases [116, 117], including NASH [118]; therefore, its activity must be tightly regulated to avoid deleterious effects.